What is it about?
Primary percutaneous coronary intervention (PPCI) is the recommended treatment in ST elevated myocardial infarction (STEMI). The determination of Quality of life (QoL) for various options of coronary revascularization is important for establishment of a comprehensive care plan. Studies of QoL in interventional cardiology are scarce. Our study has compared utility scores and quality adjusted life year (QALY) of 2nd and 3rd generation drug eluting stents (DES).
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
Studies on post-PCI and post-PPCI QoL are very limited. Therefore, this study was aimed to compare the quality of life, quality adjusted life years and predictors of QoL in coronary artery disease patients undergoing PPCI with 2nd and 3rd generation drug eluting stents.
Perspectives
This study’s results will provide valuable information to the decision makers about the use of newer generation DES and effective management of limited healthcare resources to obtain maximum benefits. The results of this study can be implemented in pharmaco-economic analysis and can assist policymakers in the allocation of scarce healthcare resources for expensive therapies and in the management of chronic diseases like CAD.
Amjad Khan
Quaid-i-Azam University
Read the Original
This page is a summary of: Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents, PLoS ONE, June 2021, PLOS,
DOI: 10.1371/journal.pone.0253290.
You can read the full text:
Resources
Contributors
The following have contributed to this page
